Being diagnosed with a serious illness such as cancer brings many physical, emotional and financial burdens, not only for patients, but for their caregivers as well. However, a new study from researchers at Wake Forest University School of Medicine shows that caregivers of adult cancer patients are often overlooked in cancer care.
Tag: Cancer Care
Patients at JFK University Medical Center to Benefit from $1 Million Gift from the Sarala Bathena Foundation
A $1 million gift to Hackensack Meridian JFK University Medical Center Foundation by the Sarala Bathena Foundation will establish the Sarala Bathena Oncology Patient Assistance Fund at Hackensack Meridian JFK University Medical Center, a not-for-profit medical center located in Edison, NJ.
UChicago Medicine breaks ground on $815M project to build state’s first freestanding cancer care and research pavilion
The University of Chicago Medicine broke ground Tuesday on its $815 million project to build the state’s first and only standalone structure dedicated to cancer care and research. The 575,000-square-foot, seven-story pavilion builds off UChicago’s decades of work and leadership in cancer research and its prestigious National Center Institute designation as a Comprehensive Cancer Center.
Blood Thinners Have Role in Cancer Care to Prevent Embolism
Analysis of anticoagulants in patients with malignant cancer shows that further study is needed to establish an adjuvant, or combined, treatment protocol.
UC San Diego Health Ranks No. 1 in San Diego, Makes National Honor Roll
U.S. News & World Report ranks 10 medical and surgical specialties at UC San Diego Health among the nation’s best.
Cancer discoveries could enhance immunotherapy, breast cancer care
Two new discoveries from the Dudley lab at UVA Cancer Center highlight the different roles of blood vessels in solid tumors – and the findings could help prevent breast cancer from spreading and enhance the effectiveness of one of the most important new cancer treatments in many years.
American Cancer Society Experts Presenting Key Research at 2023 ASCO Meeting
Scientists from the American Cancer Society are presenting research studies at the 2023 Annual Meeting of the American Society of Clinical Oncology (ASCO) June 2-6 in Chicago, Illinois.
COVID-19 Pandemic Will Disrupt Cancer Reporting for Years to Come
American College of Surgeons research published in JAMA Surgery reveals the complexities and variations that occurred in cancer reporting in the National Cancer Database (NCDB) because of the pandemic.
National Comprehensive Cancer Network Announces Collaboration with Blood Cancer Experts in Poland
The National Comprehensive Cancer Network® (NCCN®)—a not-for-profit alliance of leading United States cancer centers—announces a new collaboration with the Institute of Hematology and Transfusion Medicine in Poland (IHIT), and the Alliance For Innovation—Polish-American Foundation (AFI).
Jaime Merchán, M.D., Named a Translational and Clinical Oncology Research Program Co-Leader
Jaime Merchán, M.D., is the new Translational and Clinical Oncology Research Program co-leader at Sylvester Comprehensive Cancer Center, part of UHealth – University of Miami Health System.
Women in Medicine: Dr. Priyamvada Rai to Co-lead Tumor Biology Research Program
Priyamvada Rai, Ph.D., is the new Tumor Biology Research Program co-leader at Sylvester Comprehensive Cancer Center, part of UHealth – University of Miami Health System.
Sylvester Comprehensive Cancer Center Scientists, Collaborators Develop Powerful AI Algorithm to Gain New Insights into Deadly Glioblastoma
(MIAMI, FL, EMBARGOED UNTIL FEB. 2, 2023 AT 11 A.M. EST) — Scientists at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, collaborating with international researchers, have developed a sophisticated AI algorithm that performs advanced…
RUSH Plans New, Larger Cancer Treatment Center in Lisle
Rush University System for Health has submitted a certificate of need to the Illinois Health Facilities and Services Review Board for a RUSH Lisle location at 2455 Corporate West Drive, an approximately 55,000-square-foot comprehensive cancer center in the western suburbs.
Sylvester Comprehensive Cancer Center Receives Approval to Build World-Class Myeloma Research Institute
The Myeloma Research Institute’s launch follows many important accomplishments by C. Ola Landgren, M.D., Ph.D. and his team, who are dedicated to fulfilling a promise of providing the best cancer care to myeloma patients. Florida is among the states with the highest rates of new myeloma diagnoses in the U.S., with 7.9 cases diagnosed in every 100,000 of the state’s residents.
Improving Cancer Outcomes for LGBTQ+ Patients Requires Earning Trust and Challenging Assumptions
Annual NCCN Patient Advocacy Summit explores stories and data highlighting barriers to high-quality care that LGBTQ+ people with cancer experience, examining persistent setbacks and promising developments.
SHRO Medical Conference, Plus Honorees from Entertainment, Business, and Politics Headlining the NIAF 47th Annual Gala
The National Italian American Foundation (NIAF) will celebrate its 47th Anniversary Gala at the elegant Omni Shoreham Hotel in Washington, D.C., on Saturday, October 29, 2022.
Henry Ford Hospital Earns Prestigious Recognition from National Accreditation Program for Rectal Cancer
Henry Ford Hospital has earned a three-year accreditation from the National Accreditation Program for Rectal Cancer (NAPRC), which was developed through a collaboration between the OSTRiCh (Optimizing the Surgical Treatment of Rectal Cancer) consortium and the Commission on Cancer, a quality program of the American College of Surgeons.
New Study Shines Light on Financial Resources for Women with Breast Cancer
A new study published in Clinical Breast Cancer shines a light on the significant financial burden associated with breast cancer treatment. The study, “Mitigating Financial Toxicity in Breast Cancer from Diagnosis to Treatment and Reconstruction,” was co-authored by Nikita Roy…
$1.8 Million NIH Grant Supports Head and Neck Cancer Research
Sylvester Comprehensive Cancer Center researchers Lluis Morey, Ph.D., and Ramiro Verdun, Ph.D., have received a $1.8 million NIH R01 grant to study the epigenetic mechanisms that drive head and neck cancers.
Sylvester Game Changer Vehicle Among First in Nation to Offer Mobile Prostate Cancer Screening
Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine’s Game Changer vehicles, which bring health education and free screenings for many cancer types to South Florida communities in need, are for the first time offering prostate-specific antigen (PSA) screening for prostate cancer.
Sylvester Leads Study on New Treatment Option for Brain Tumor that Relapses or Fails to Respond to Standard of Care
Taken twice daily, oral olutasidenib helped to stabilize relapsed or refractory gliomas in heavily pretreated patients with less toxicity than standard of care treatment, according to a study led by Sylvester Comprehensive Cancer Center at the University of Miami School…
Sylvester Plays Pivotal Role in Practice-Changing Anal Cancer Prevention Study Published by NEJM
The New England Journal of Medicine (NEJM) has published the results of a study by Sylvester Comprehensive Cancer Center at the University of Miami Miller School and other investigators on anal cancer prevention in people living with HIV (PLHIV) that will likely establish a…
Mayo Clinic, Médica Sur expand relationship to advance cancer care
Médica Sur, the first international member of the Mayo Clinic Care Network, and Mayo Clinic will deepen their relationship by working together to advance cancer care at Médica Sur. The new collaboration will begin July 1.
Sylvester Researchers Study Vaginal Microbiome’s Role in Screening for Endometrial Cancer
The vaginal microbiome differentiates benign disease from endometrial cancer and can even provide insight about the specific endometrial cancer type and disease severity, according to a study by investigators at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of…
Sylvester Announces Transformational Cancer Research Building
Sylvester Comprehensive Cancer Center is making another bold move to accelerate cancer research, celebrating the groundbreaking for a 244,000-square-foot, state-of-the-art Sylvester Comprehensive Cancer Center – Transformational Cancer Research Building (TCRB).
Public Beware: Study Finds Potential for Massive Cancer Nutrition Misinformation on Pinterest
A multi-center team including researchers from Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine claims that the social media site Pinterest is rife with cancer misinformation. Their study found that about a third of posts…
Memorial Sloan Kettering Cancer Center Announces Transformative Gift to Establish the Nonna’s Garden Foundation Initiative for Cancer Care and Research
Memorial Sloan Kettering Cancer Center (MSK) today announced a generous $50 million gift from Mike and Maria Repole and the Nonna’s Garden Foundation to establish The Nonna’s Garden Foundation Initiative for Cancer Care and Research at MSK.
Rutgers Cancer Institute of New Jersey and RWJBarnabas Health Launch State’s First Home Infusion Program
Rutgers Cancer Institute of New Jersey and RWJBarnabas Health have partnered with Horizon Blue Cross Blue Shield of New Jersey to launch a collaborative pilot program which provides oncology care to eligible patients in the comfort of their own home – the first of its kind in the state.
Memorial Sloan Kettering Cancer Center Appoints Tracy Gosselin as Senior Vice President, Chief Nurse Executive, and Chair of Nursing
Memorial Sloan Kettering Cancer Center (MSK) has appointed Tracy Gosselin, PhD, RN, AOCN, NEA-BC, FAAN, as Senior Vice President, Chief Nurse Executive, and Chair of Nursing effective November 2021. Dr. Gosselin currently serves as Chief Nursing & Patient Care Services Officer, Duke University Hospital.
Rutgers Faculty Receives Grant to Improve End-of-Life Cancer Care
Paul Duberstein, chair of the Department of Health Behavior, Society, and Policy at Rutgers School of Public Health and associate research member at Rutgers Cancer Institute of New Jersey, has received a New Jersey Commission on Cancer Research grant to evaluate the impact of a communication intervention that seeks to improve the care of patients with advanced cancer.
Princess Margaret Cancer Centre researchers discover key stem cell dormancy mechanism which could help unlock future cancer treatments
Princess Margaret Cancer Centre researchers have made new findings which provide a broader understanding of how dormant hematopoietic stem cells are activated and could pave the way towards therapeutic treatments for a number of cancers.
Rush University Medical Center Again on U.S. News & World Report Honor Roll
Of the more than 3,000 U.S. hospitals evaluated, Rush University Medical Center ranked No. 19 in the nation by U.S. News & World Report, with nine of specialties rated among the country’s very best.
Study of Cancer Patients and COVID-19 Highlights Health Disparities
Findings from a study led by researchers at Henry Ford Cancer Institute, in collaboration with Advocate Aurora Health, the Food and Drug Administration and Syapse®, show an elevated risk for severe COVID-19 effects or death among patients with cancer, with the highest risk being among low-income and Black patients.
‘COVID-19 & Cancer Care’ briefing March 30 features new survey data from leaders of physician and survivor groups
Experts from the American Society for Radiation Oncology (ASTRO) and the National Coalition for Cancer Survivorship (NCCS) will discuss the impact of the COVID-19 pandemic on cancer diagnoses and care during a virtual media briefing on Tuesday, March 30, 2021,…
Memorial Sloan Kettering and the Cancer Community Urge Americans to Resume Cancer Screenings and Treatment
Early detection helps improve patient outcomes, but data shows that many cancers are going undiagnosed or untreated because of COVID-19.
Dana-Farber to hold a discussion for cancer patients and survivors about the Covid-19 vaccine
Dana-Farber Cancer Institute is having a virtual discussion for cancer patients and survivors about the Covid-19 vaccine on January 27, 2020 at 5 pm.
Personalizing Cancer Care with Improved Tumor Models
While decades of research have resulted in substantial improvements in surviving cancer, a key challenge remains in identifying new drugs that improve outcomes for patients. In APL Bioengineering, researchers suggest a major hurdle is the paucity of models for cancer research that accurately represent patient tumors. They provide a perspective on strategies using models from individual patients and where the field needs to go in terms of research in animal systems and in culture systems.
Changes Needed to Address Financial Hardship from Cancer
Until you or a loved one are facing treatment for a cancer diagnosis, you may not realize the cost associated with treatment and doctor visits.
First Report Card on Biosimilars in Oncology
SUMMARY Researchers have developed the first report card on biosimilars for three blockbuster cancer drugs marketed by Genentech/Roche: Rituxan, Avastin and Herceptin. In a Policy Review in The Lancet Oncology, Y. Tony Yang, a professor at the George Washington University…
The Impact of the Coronavirus Pandemic on Cancer Care
Andrew M. Evens, the associate director for clinical services and director of the lymphoma program at Rutgers Cancer Institute and the medical director of oncology services at RWJBarnabas Health, discusses the impact of the COVID-19 pandemic on cancer care.
New tools to improve care for cancer that has spread to the brain
The tools will help doctors and patients make better-informed treatment decisions, enhance the care of brain metastases, and enable hospitals to improve the coordination and effectiveness of their interdisciplinary treatment programs.
Black Lives Also Matter in Cancer Care
Studies have long reported that Black cancer patients have poorer outcomes than their white counterparts.
What Does it Mean to be An NCI-Designated Comprehensive Cancer Center?
Rutgers Cancer Institute is a National Cancer Institute-designated Comprehensive Cancer Center, a designation reserved for those cancer centers who meet the highest of standards in research, treatment, prevention and education. Rutgers Cancer Institute expert explains why this distinction sets Rutgers Cancer Institute and RWJBarnabas Health apart.
Cancer vs. COVID: When a pandemic upended cancer care
A team of researchers interviewed physicians and patients at the beginning of the COVID-19 pandemic to identify eight scenarios impacting cancer care. Using communication strategies, they created examples of language to help oncologists respond to patients empathetically.
Nationwide Trends Show Fewer Cancer Patients Seeking Care Since Start of Pandemic
Researchers observe significant decreases nationwide in the number of patients being seen for cancer-related care as the COVID-19 pandemic progressed during the few first months of 2020.
Seattle Cancer Care Alliance Announces Paula Rosput Reynolds as new Chair of its Board of Directors
Seattle Cancer Care Alliance (SCCA) announced that Paula Rosput Reynolds will become chair of its Board of Directors. Reynolds takes the helm of the SCCA board from Karen Glover, who served as chair since 2018.
Seattle Cancer Care Alliance Expands South Lake Union Campus
Seattle Cancer Care Alliance (SCCA) announced the beginning of construction on its South Lake Union (SLU) campus to add a new six-story, 150,000 square-foot outpatient cancer treatment clinic.
Your Cancer Care is too Important to Wait
Minimizing your exposure to COVID-19 doesn’t require sacrificing cancer care or preventive services. Rutgers Cancer Institute of New Jersey and RWJBarnabas Health are taking extra precautions to ensure that patients can continue to receive exceptional care close to home.
Coming Home to Fight Cancer
For Erika Maestas, MD, the journey to UNM Cancer Center is a journey home. Maestas grew up in Albuquerque, while her parents hailed from rural northern New Mexico. She likes that the UNM Cancer Center’s cutting edge research into cancer treatments gives her a chance to continue learning while continuing to do what she loves: working with patients
National Comprehensive Cancer Network Releases Recommendations for Standardizing Quality Measurements in Oncology
The National Comprehensive Cancer Network (NCCN) has published a curated list of high-impact measures for assessing quality improvements in cancer care. The recommendations reflect a landscape analysis from leading oncology experts in order to move the needle on cancer care standards in America.